• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

描述癌症中心集水区的淋巴瘤发病率和差异。

Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

机构信息

Winship Cancer Institute, Atlanta, GA.

Winship Cancer Institute, Atlanta, GA; Rollins School of Public Health, Emory University, Atlanta, GA.

出版信息

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):699-708.e5. doi: 10.1016/j.clml.2019.06.009. Epub 2019 Jun 26.

DOI:10.1016/j.clml.2019.06.009
PMID:31494062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6875621/
Abstract

BACKGROUND

Racial disparities in non-Hodgkin lymphoma (NHL) are not well-elucidated for specific catchment areas, which can influence outcomes. Leveraging regional data from a population-based cancer registry may provide unique opportunities to quantify NHL disparities.

MATERIALS AND METHODS

Using Surveillance, Epidemiology, and End Results (SEER) data for NHL cases diagnosed in Georgia from 2001 to 2015, we examined NHL incidence rates by lymphoma subtype and racial differences in baseline characteristics and outcomes for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). Cox regression models identified predictors of overall survival (OS).

RESULTS

SEER documented 38,504 NHL cases in Georgia from 2001 to 2015. The age-adjusted incidence rate for NHL in Georgia increased 1.03% per year, and the annual percentage change was 1.72 in blacks compared with 0.84 in whites. Compared with whites, blacks with DLBCL and FL were more likely to be diagnosed at a younger age (DLBCL, 54.1 vs. 65.5 years; P < .0001; FL, 58.4 vs. 64.0 years; P < .0001) and with B symptoms (DLBCL, 44.4% vs. 33.4%; P < .0001; FL, 28.5% vs. 21.4%; P = .004). Across racial categories, age at diagnosis > 60 years, advanced stage, and B symptoms predicted worse OS in DLBCL and FL. Blacks with DLBCL more commonly were diagnosed with stage III/IV disease (55.5% vs. 48.1%; P < .0001) and had worse 5-year relative survival (58.8% vs. 62.3%; P = .01).

CONCLUSIONS

Regional cancer registry data can be used to define incidence patterns and disparities in outcomes across NHL subtypes to help define key targets for interventions in a catchment area.

摘要

背景

非霍奇金淋巴瘤(NHL)在特定的普查区域内种族差异尚未得到充分阐明,而这些差异可能会影响预后。利用基于人群的癌症登记处的区域数据可能为量化 NHL 差异提供独特的机会。

材料与方法

我们使用 2001 年至 2015 年期间佐治亚州监测、流行病学和最终结果(SEER)数据库中诊断的 NHL 病例数据,通过淋巴瘤亚型和弥漫性大 B 细胞淋巴瘤(DLBCL)和滤泡性淋巴瘤(FL)的基线特征和结局的种族差异,检查 NHL 的发病率。Cox 回归模型确定了总生存(OS)的预测因素。

结果

SEER 在 2001 年至 2015 年期间记录了佐治亚州的 38504 例 NHL 病例。佐治亚州 NHL 的年龄调整发病率每年增加 1.03%,而黑人的年变化率为 1.72%,白人则为 0.84%。与白人相比,患有 DLBCL 和 FL 的黑人更有可能在较年轻时被诊断出(DLBCL,54.1 岁对 65.5 岁;P <.0001;FL,58.4 岁对 64.0 岁;P <.0001)且有 B 症状(DLBCL,44.4%对 33.4%;P <.0001;FL,28.5%对 21.4%;P =.004)。在各种种族类别中,年龄 > 60 岁、晚期疾病和 B 症状预测 DLBCL 和 FL 的 OS 更差。患有 DLBCL 的黑人更常见地被诊断为 III/IV 期疾病(55.5%对 48.1%;P <.0001),并且 5 年相对生存率更差(58.8%对 62.3%;P =.01)。

结论

区域癌症登记处的数据可用于定义 NHL 亚型的发病模式和结局差异,以帮助确定普查区域内干预的关键目标。

相似文献

1
Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.描述癌症中心集水区的淋巴瘤发病率和差异。
Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):699-708.e5. doi: 10.1016/j.clml.2019.06.009. Epub 2019 Jun 26.
2
Racial differences in three major NHL subtypes: descriptive epidemiology.三种主要非霍奇金淋巴瘤亚型的种族差异:描述性流行病学
Cancer Epidemiol. 2015 Feb;39(1):8-13. doi: 10.1016/j.canep.2014.12.001. Epub 2015 Jan 2.
3
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.美国弥漫性大 B 细胞淋巴瘤的临床表现和结局存在种族差异。
Cancer. 2011 Jun 1;117(11):2530-40. doi: 10.1002/cncr.25765. Epub 2010 Dec 22.
4
Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.非霍奇金淋巴瘤患者的心血管死亡率:根据淋巴瘤亚型的差异。
Hematol Oncol. 2019 Aug;37(3):261-269. doi: 10.1002/hon.2607. Epub 2019 Apr 12.
5
Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence.农村、种族和民族对非霍奇金淋巴瘤发病率的影响。
Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):668-676.e5. doi: 10.1016/j.clml.2020.05.010. Epub 2020 May 16.
6
Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.非霍奇金淋巴瘤亚型对死亡率趋势的影响
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):174-9. doi: 10.1158/1055-9965.EPI-15-0921. Epub 2015 Oct 15.
7
Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.非霍奇金淋巴瘤:利妥昔单抗对弥漫性大 B 细胞淋巴瘤和滤泡性淋巴瘤患者总生存的影响。
Arch Med Res. 2015 Aug;46(6):454-61. doi: 10.1016/j.arcmed.2015.07.004. Epub 2015 Jul 31.
8
Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.美国白种人、黑人和亚洲/太平洋岛民中非霍奇金淋巴瘤的发病情况:解剖部位和组织学差异。
Cancer Epidemiol. 2009 Nov;33(5):337-46. doi: 10.1016/j.canep.2009.09.006. Epub 2009 Oct 22.
9
Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.环境紫外线辐射与非霍奇金淋巴瘤亚型之间的关系:一项基于美国人群的种族和族裔群体研究。
Int J Cancer. 2015 Mar 1;136(5):E432-41. doi: 10.1002/ijc.29237. Epub 2014 Oct 13.
10
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.利用基于人群的数据调查 2008 年至 2017 年期间台湾和美国滤泡性淋巴瘤的发病趋势。
PLoS One. 2022 Mar 17;17(3):e0265543. doi: 10.1371/journal.pone.0265543. eCollection 2022.

引用本文的文献

1
Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry.非洲裔患者慢性淋巴细胞白血病的基因组特征分析。
Blood Cancer J. 2025 Feb 6;15(1):14. doi: 10.1038/s41408-024-01207-3.
2
New strategies for enhancing enrollment of underrepresented minorities in lymphoma clinical trials.提高淋巴瘤临床试验中代表性不足的少数群体入组率的新策略。
Blood Adv. 2025 Feb 25;9(4):774-782. doi: 10.1182/bloodadvances.2024012981.
3
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity.

本文引用的文献

1
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.使用多状态模型评估高危滤泡性淋巴瘤老年患者治疗序列的有效性。
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):300-309.e5. doi: 10.1016/j.clml.2018.12.019. Epub 2019 Jan 3.
2
Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.农村和城市弥漫大 B 细胞淋巴瘤和滤泡性淋巴瘤患者的总生存时间降低:一项国家癌症数据库研究。
Leuk Lymphoma. 2019 Jul;60(7):1656-1667. doi: 10.1080/10428194.2018.1546855. Epub 2019 Jan 11.
3
真实世界和临床试验中 axicabtagene ciloleucel 治疗大 B 细胞淋巴瘤的结局与种族和民族有关。
Blood. 2024 Jun 27;143(26):2722-2734. doi: 10.1182/blood.2023023447.
4
Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities.乙型肝炎病毒与B细胞淋巴瘤:证据、未满足的需求、临床影响及机遇
Front Oncol. 2023 Oct 20;13:1275800. doi: 10.3389/fonc.2023.1275800. eCollection 2023.
5
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.非霍奇金淋巴瘤幸存者的继发性恶性肿瘤:通过治疗方式评估 40 年的随访结果。
Cancer Med. 2023 Feb;12(3):2624-2636. doi: 10.1002/cam4.5139. Epub 2022 Aug 17.
6
Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients.回顾性分析皮肤 T 细胞淋巴瘤中的脓毒症,发现黑人患者的风险显著增加。
J Am Acad Dermatol. 2023 Feb;88(2):329-337. doi: 10.1016/j.jaad.2022.10.029. Epub 2022 Oct 17.
7
Perceptions of clinical care and research among African-American patients with lymphoma.非裔美国淋巴瘤患者对临床护理和研究的看法。
Leuk Lymphoma. 2021 Aug;62(8):1860-1868. doi: 10.1080/10428194.2021.1892092. Epub 2021 Feb 28.
Cancer statistics, 2019.
癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
4
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中体细胞核因子调控变异的全基因组发现
Nat Commun. 2018 Oct 1;9(1):4001. doi: 10.1038/s41467-018-06354-3.
5
Disparities in survival by insurance status in follicular lymphoma.滤泡性淋巴瘤患者的保险状况与生存率的差异。
Blood. 2018 Sep 13;132(11):1159-1166. doi: 10.1182/blood-2018-03-839035. Epub 2018 Jul 24.
6
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.弥漫性大 B 细胞淋巴瘤的分子亚型与不同的发病机制和预后相关。
Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30.
7
Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.青少年和年轻成人霍奇金淋巴瘤幸存者中医疗状况发生情况的社会人口学差异。
Cancer Causes Control. 2018 Jun;29(6):551-561. doi: 10.1007/s10552-018-1025-0. Epub 2018 Apr 13.
8
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传学与发病机制
N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.
9
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传和功能驱动因素
Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.
10
Relations Between Residential Proximity to EPA-Designated Toxic Release Sites and Diffuse Large B-Cell Lymphoma Incidence.居住地与美国环境保护局指定的有毒物质排放场所的距离与弥漫性大B细胞淋巴瘤发病率之间的关系。
South Med J. 2016 Oct;109(10):606-614. doi: 10.14423/SMJ.0000000000000545.